Point of Care Diagnostics: Technologies and Global Markets
Point of Care Diagnostics: Technologies and Global Markets
Abstract
Report Scope:
The current report offers a detailed picture of the point of care diagnostics market.
This report highlights the current and future market potential for point of care diagnostics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections through 2026, as well as key market players.
This report discusses the point of care diagnostics industry and its various resources. It covers the overall point of care diagnostics market including hardware (devices, equipment, consumables (reagents and kits)), software and analytics. The report further analyzes the market based on test type, providing an analysis of alcohol and drug abuse, BGEM, cardiac markers, cholesterol, glucose monitoring, hemoglobin/hemostasis, infectious disease, pregnancy and fertility, tumor markers, urine chemistry and others. A complete regional analysis of the market is also studied in the report.
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa. Detailed analyses of major countries include the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China, and India. For market estimates, data have been provided for 2020 as the base year, with forecasts for 2021 through 2026. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes:
- 59 data tables and 40 additional tables
- An overview of the global markets and technologies for point of care (POC) diagnostics within healthcare industry
- Estimation of market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation of current market trends, and technological advancements within the industry and market share analysis by test type, product, end user, and region
- Coverage of novel approaches for the POC; discussion on significance of CLIA in the United States and FDA’s role in POC testing; and information on laser PCR
- Detailed description about COVID-19 impact on MedTech and medical tourism, discussion on FDA’s contribution to COVID-19 diagnostic testing and synopsis of FDA-Associated testing milestones since May 2020
- Detailed analysis of relevant R&D activities, new products launches and product enhancement in the industry, clinical trials, and discussion of regulatory elements that are affecting the future marketplace
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Company profiles of major players of the industry, including Abbott, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Medtronic plc, Chembio Diagnostics Inc. and Philips Healthcare
Content
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
What's New in this Report?
Scope of Report
Defining POC Testing
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Overview
Chapter 3 Market and Technology Background
Overview
Novel Approaches for POC
Laser PCR: Expanding the Possibilities at the POC
Significance of CLIA in the United States
Regulatory Guidelines
The FDA's Role in POC Testing
Good Manufacturing Practice
Conclusion
Chapter 4 Market Dynamics
Drivers
High Incidences of Infectious Diseases
Increasing R&D Budget
Aging Population
Opportunities
COVID-19
Emerging Economies
Chapter 5 COVID-19 Impact Analysis
Introduction
Impact on MedTech
Elective and Noncritical Procedures
Shift in Manufacturing
Regulatory Delays, Clinical Trials and Product Launches
Supply Chain Disruptions
Medical Tourism
FDA's Contribution to COVID-19 Diagnostic Testing
Prioritizing of OTC and At-Home Testing Solutions
Synopsis of FDA-Associated Testing Milestones Since May 2020
Chapter 6 Global Point of Care Diagnostics Market, by Test Type
BGEM
Electrolytes
CLIA Quality Control Requirements for Blood Gas Analysis
Market Size and Forecast
Cardiac Markers
Market Size and Forecast
Cholesterol Testing/Monitoring
Market Size and Forecast
Drug and Alcohol Screening
Market Size and Forecast
Glucose Testing and Monitoring
Market Size and Forecast
Infectious Disease Testing
Market Size and Forecast
Pregnancy and Fertility Testing
Market Size and Forecast
Hemoglobin and Hemostasis
Hematology and Hemostasis
Hemostasis (Coagulation)
Market Size and Forecast
Tumor Marker
Fecal and Gastric Occult Blood
Bladder Tumor Antigen Test
Market Size and Forecast
Urinalysis/Urine Chemistry
Market Size and Forecast
Others
Vaginal pH Tests
Thyroid Stimulating Hormone Tests
Male Reproductive Tests
Menopause
Dry Eye
Market Size and Forecast
Chapter 7 Market Breakdown by Product
Hardware
Market Size and Forecast
Software
Market Size and Forecast
Chapter 8 Market Breakdown by End User
Home Care Settings
Market Size and Forecast
Hospitals and Critical Care Settings
Critical-Care Units
Bedside Testing
Operating Rooms/Procedure Rooms
Physicians' Offices/Clinics/Treatment Centers/Other Noncritical-Care Sites
Nursing Homes and Hospice
Market Size and Forecast
Chapter 9 Market Breakdown by Region
Global Market for Point of Care Diagnostics by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World (RoW)
Market Size and Forecast
Chapter 10 Competitive Landscape
Overview
Company Share Analysis
Strategies
Regional Distributors
End Users
Recent Developments
Chapter 11 Company Profiles
ABAXIS
ABBOTT
BECTON, DICKINSON AND CO.
BIO-RAD LABORATORIES INC.
CARDINAL HEALTH
CHEMBIO DIAGNOSTICS
DANAHER CORP.
EKF DIAGNOSTICS HOLDINGS PLC
ELITECH GROUP
ESAOTE S.P.A.
GENERAL ELECTRIC
LIFESCAN
LUMOS DIAGNOSTICS HOLDINGS LTD.
MEDTRONIC PLC
MINDRAY MEDICAL INTERNATIONAL LTD.
NEXUS DX
NOVA BIOMEDICAL
ORASURE TECHNOLOGIES
PHILIPS HEALTHCARE
QUIDEL
ROCHE HOLDING AG (F. HOFFMANN-LA ROCHE LTD.)
SIEMENS HEALTHCARE
THERMO FISHER SCIENTIFIC INC.
ZOETIS INC.
List of Tables
Summary Table : Global Market for Point of Care Diagnosis, by Region, Through 2026
Table 1 : Synonyms of POCT
Table 2 : Clinical Outcomes from Using Point of Care Testing
Table 3 : Commercial Systems for Near Patient Testing
Table 4 : Selected CLIA-Waived POC Tests
Table 5 : CLIA-Waived Tests Applications, by Test System/Manufacturers, 2018–October 2021
Table 6 : GMP Regulations Relevant Parameters Affecting In Vitro Diagnostics
Table 7 : Global HIV Data, 2000-2020
Table 8 : Global Estimated Number of New Cases of Curable STIs, 2019
Table 9 : Estimated Global Population and Annual Growth, by Selected Age Group and Selected Years, Through 2030
Table 10 : Global Geriatric Population (60 Years+), by Region, 2015-2050
Table 11 : Number of Deaths Due to COVID-19 Worldwide, by Country, as of Dec. 4, 2020
Table 12 : Leading Causes of Diseases around the World, 2004 and 2030
Table 13 : Global Market for Point of Care Diagnostics, by Test Type, Through 2026
Table 14 : Global Market for BGEM, by Region, Through 2026
Table 15 : Global Deaths from CVD, 2015 and 2030
Table 16 : Global Market for Cardiac Markers, by Region, Through 2026
Table 17 : Global Market for Cholesterol Testing/Monitoring, by Region, Through 2026
Table 18 : Prevalence of Cannabis Use, by Region, 2019
Table 19 : Global Market for Drug and Alcohol Screening, by Region, Through 2026
Table 20 : Diabetes Patients by Region, 2019, 2030 and 2045
Table 21 : Global Market for Glucose Testing and Monitoring, by Region, Through 2026
Table 22 : Global Market for Infectious Disease Testing, by Region, Through 2026
Table 23 : Global Market for Pregnancy and Fertility Testing, by Region, Through 2026
Table 24 : Global Market for Hemoglobin and Hemostasis, by Region, Through 2026
Table 25 : Global Deaths from Cancer, 2015 and 2030
Table 26 : Global Market for Tumor Markers, by Region, Through 2026
Table 27 : Global Market for Urinalysis/Urine Chemistry, by Region, Through 2026
Table 28 : Global Market for Others, by Region, Through 2026
Table 29 : Global Market for Point of Care Diagnostics, by Product, Through 2026
Table 30 : Global Market for Hardware in Point of Care Diagnostics, by Region, Through 2026
Table 31 : Global Market for Software in Point of Care Diagnostics, by Region, Through 2026
Table 32 : Global Market for Point of Care Diagnostics, by End User, Through 2026
Table 33 : Global Market for Point of Care Diagnostics in Home Care Settings, by Region, Through 2026
Table 34 : Estimated Number of Hospitals Beds Available, by Country, 2018-2019
Table 35 : Estimated Nursing Homes Residents in U.S., by U.S. State, 2020
Table 36 : Number of Hospice Providers in America, by Type, in 2018
Table 37 : Global Market for Point of Care Diagnostics in Hospital and Critical Care End Use, by Region, Through 2026
Table 38 : Global Market for Point of Care Diagnostics, by Region, Through 2026
Table 39 : North American Market for Point of Care Diagnostics, by Test Type, Through 2026
Table 40 : North American Market for Point of Care Diagnostics, by Product, Through 2026
Table 41 : North American Market for Point of Care Diagnostics, by End User, Through 2026
Table 42 : North American Market for Point of Care Diagnostics, by Country, Through 2026
Table 43 : COVID-19 Confirmed Cases and Deaths in the U.S., by State
Table 44 : STI Cases Across Canada, by Gender and Disease Type, 2018
Table 45 : European Market for Point of Care Diagnostics, by Test Type, Through 2026
Table 46 : European Market for Point of Care Diagnostics, by Product, Through 2026
Table 47 : European Market for Point of Care Diagnostics, by End User, Through 2026
Table 48 : European Market for Point of Care Diagnostics, by Country, Through 2026
Table 49 : Geriatric Population in Germany, 2015-2030
Table 50 : Health Spending and Financing in France, 2005-2017
Table 51 : New Cancer Cases in Spain, by Type, 2020
Table 52 : Asia-Pacific Market for Point of Care Diagnostics, by Test Type, Through 2026
Table 53 : Asia-Pacific Market for Point of Care Diagnostics, by Product, Through 2026
Table 54 : Asia-Pacific Market for Point of Care Diagnostics, by End User, Through 2026
Table 55 : Asia-Pacific Market for Point of Care Diagnostics, by Country, Through 2026
Table 56 : Japanese Market Statistics
Table 57 : Commonly Used POC Devices in the Indian Healthcare System.
Table 58 : Rest of the World Market for Point of Care Diagnostics, by Test Type, Through 2026
Table 59 : Rest of the World Market for Point of Care Diagnostics, by Product, Through 2026
Table 60 : Rest of the World Market for Point of Care Diagnostics, by End User, Through 2026
Table 61 : Middle East and North Africa HIV and AIDS Statistics, 2019
Table 62 : Recent Developments in Point of Care Diagnostics Market, 2019-2021
Table 63 : Abbaxis: Point of Care Diagnostic/Testing Products
Table 64 : Abbott: Financials, 2016-2020
Table 65 : Abbott: Product Portfolio, by Business Segment
Table 66 : Abbott: Point of Care Diagnostic Products
Table 67 : Abbott: Recent Developments, 2021
Table 68 : BD: Product Portfolio
Table 69 : BioRad Laboratories Product Portfolio
Table 70 : Cardinal Health Inc.: Product Portfolio
Table 71 : Chembio Diagnostics Inc.: Product Portfolio
Table 72 : Chembio Diagnostics: Recent Developments, 2021
Table 73 : Danaher Product Portfolio
Table 74 : EKF Diagnostics Holdings plc: Product Portfolio
Table 75 : ELITech Group: Product Portfolio
Table 76 : Esaote S.p.A.: Product Portfolio
Table 77 : GE: Financial Performance, 2019 and 2020
Table 78 : GE Healthcare: Point of Care Diagnostics Products
Table 79 : LifeScan Product Portfolio
Table 80 : Lumos Diagnostics Holdings Ltd.: Product Portfolio
Table 81 : Medtronic plc: Product Portfolio
Table 82 : Mindray Medical International Ltd.: Product Portfolio
Table 83 : Nexus DX: Product Portfolio
Table 84 : Nova Biomedical Product Portfolio
Table 85 : OraSure Technologies: Product Portfolio
Table 86 : Philips Healthcare: Product Portfolio
Table 87 : Quidel Corp.: Product Portfolio
Table 88 : F. Hoffmann-La Roche Ltd.: Financials, 2019
Table 89 : F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2016-2018
Table 90 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 91 : F. Hoffmann-La Roche Ltd.: Recent Developments, 2021
Table 92 : Siemens Healthcare GmbH: Product Segments
Table 93 : Siemens Healthcare GmbH: Point of Care Diagnostics Products
Table 94 : Siemens Healthcare GmbH: Financials, 2019
Table 95 : Siemens Healthcare GmbH: Key Developments, 2020
Table 96 : Thermo Fisher Scientific: Product Portfolio
Table 97 : Thermo Fisher Scientific: Key Developments, 2021
Table 98 : Zoetis Inc. Product Portfolio
Report Scope:
The current report offers a detailed picture of the point of care diagnostics market.
This report highlights the current and future market potential for point of care diagnostics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections through 2026, as well as key market players.
This report discusses the point of care diagnostics industry and its various resources. It covers the overall point of care diagnostics market including hardware (devices, equipment, consumables (reagents and kits)), software and analytics. The report further analyzes the market based on test type, providing an analysis of alcohol and drug abuse, BGEM, cardiac markers, cholesterol, glucose monitoring, hemoglobin/hemostasis, infectious disease, pregnancy and fertility, tumor markers, urine chemistry and others. A complete regional analysis of the market is also studied in the report.
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa. Detailed analyses of major countries include the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China, and India. For market estimates, data have been provided for 2020 as the base year, with forecasts for 2021 through 2026. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes:
- 59 data tables and 40 additional tables
- An overview of the global markets and technologies for point of care (POC) diagnostics within healthcare industry
- Estimation of market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation of current market trends, and technological advancements within the industry and market share analysis by test type, product, end user, and region
- Coverage of novel approaches for the POC; discussion on significance of CLIA in the United States and FDA’s role in POC testing; and information on laser PCR
- Detailed description about COVID-19 impact on MedTech and medical tourism, discussion on FDA’s contribution to COVID-19 diagnostic testing and synopsis of FDA-Associated testing milestones since May 2020
- Detailed analysis of relevant R&D activities, new products launches and product enhancement in the industry, clinical trials, and discussion of regulatory elements that are affecting the future marketplace
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Company profiles of major players of the industry, including Abbott, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Medtronic plc, Chembio Diagnostics Inc. and Philips Healthcare
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
What's New in this Report?
Scope of Report
Defining POC Testing
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Overview
Chapter 3 Market and Technology Background
Overview
Novel Approaches for POC
Laser PCR: Expanding the Possibilities at the POC
Significance of CLIA in the United States
Regulatory Guidelines
The FDA's Role in POC Testing
Good Manufacturing Practice
Conclusion
Chapter 4 Market Dynamics
Drivers
High Incidences of Infectious Diseases
Increasing R&D Budget
Aging Population
Opportunities
COVID-19
Emerging Economies
Chapter 5 COVID-19 Impact Analysis
Introduction
Impact on MedTech
Elective and Noncritical Procedures
Shift in Manufacturing
Regulatory Delays, Clinical Trials and Product Launches
Supply Chain Disruptions
Medical Tourism
FDA's Contribution to COVID-19 Diagnostic Testing
Prioritizing of OTC and At-Home Testing Solutions
Synopsis of FDA-Associated Testing Milestones Since May 2020
Chapter 6 Global Point of Care Diagnostics Market, by Test Type
BGEM
Electrolytes
CLIA Quality Control Requirements for Blood Gas Analysis
Market Size and Forecast
Cardiac Markers
Market Size and Forecast
Cholesterol Testing/Monitoring
Market Size and Forecast
Drug and Alcohol Screening
Market Size and Forecast
Glucose Testing and Monitoring
Market Size and Forecast
Infectious Disease Testing
Market Size and Forecast
Pregnancy and Fertility Testing
Market Size and Forecast
Hemoglobin and Hemostasis
Hematology and Hemostasis
Hemostasis (Coagulation)
Market Size and Forecast
Tumor Marker
Fecal and Gastric Occult Blood
Bladder Tumor Antigen Test
Market Size and Forecast
Urinalysis/Urine Chemistry
Market Size and Forecast
Others
Vaginal pH Tests
Thyroid Stimulating Hormone Tests
Male Reproductive Tests
Menopause
Dry Eye
Market Size and Forecast
Chapter 7 Market Breakdown by Product
Hardware
Market Size and Forecast
Software
Market Size and Forecast
Chapter 8 Market Breakdown by End User
Home Care Settings
Market Size and Forecast
Hospitals and Critical Care Settings
Critical-Care Units
Bedside Testing
Operating Rooms/Procedure Rooms
Physicians' Offices/Clinics/Treatment Centers/Other Noncritical-Care Sites
Nursing Homes and Hospice
Market Size and Forecast
Chapter 9 Market Breakdown by Region
Global Market for Point of Care Diagnostics by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World (RoW)
Market Size and Forecast
Chapter 10 Competitive Landscape
Overview
Company Share Analysis
Strategies
Regional Distributors
End Users
Recent Developments
Chapter 11 Company Profiles
ABAXIS
ABBOTT
BECTON, DICKINSON AND CO.
BIO-RAD LABORATORIES INC.
CARDINAL HEALTH
CHEMBIO DIAGNOSTICS
DANAHER CORP.
EKF DIAGNOSTICS HOLDINGS PLC
ELITECH GROUP
ESAOTE S.P.A.
GENERAL ELECTRIC
LIFESCAN
LUMOS DIAGNOSTICS HOLDINGS LTD.
MEDTRONIC PLC
MINDRAY MEDICAL INTERNATIONAL LTD.
NEXUS DX
NOVA BIOMEDICAL
ORASURE TECHNOLOGIES
PHILIPS HEALTHCARE
QUIDEL
ROCHE HOLDING AG (F. HOFFMANN-LA ROCHE LTD.)
SIEMENS HEALTHCARE
THERMO FISHER SCIENTIFIC INC.
ZOETIS INC.
List of Tables
Summary Table : Global Market for Point of Care Diagnosis, by Region, Through 2026
Table 1 : Synonyms of POCT
Table 2 : Clinical Outcomes from Using Point of Care Testing
Table 3 : Commercial Systems for Near Patient Testing
Table 4 : Selected CLIA-Waived POC Tests
Table 5 : CLIA-Waived Tests Applications, by Test System/Manufacturers, 2018–October 2021
Table 6 : GMP Regulations Relevant Parameters Affecting In Vitro Diagnostics
Table 7 : Global HIV Data, 2000-2020
Table 8 : Global Estimated Number of New Cases of Curable STIs, 2019
Table 9 : Estimated Global Population and Annual Growth, by Selected Age Group and Selected Years, Through 2030
Table 10 : Global Geriatric Population (60 Years+), by Region, 2015-2050
Table 11 : Number of Deaths Due to COVID-19 Worldwide, by Country, as of Dec. 4, 2020
Table 12 : Leading Causes of Diseases around the World, 2004 and 2030
Table 13 : Global Market for Point of Care Diagnostics, by Test Type, Through 2026
Table 14 : Global Market for BGEM, by Region, Through 2026
Table 15 : Global Deaths from CVD, 2015 and 2030
Table 16 : Global Market for Cardiac Markers, by Region, Through 2026
Table 17 : Global Market for Cholesterol Testing/Monitoring, by Region, Through 2026
Table 18 : Prevalence of Cannabis Use, by Region, 2019
Table 19 : Global Market for Drug and Alcohol Screening, by Region, Through 2026
Table 20 : Diabetes Patients by Region, 2019, 2030 and 2045
Table 21 : Global Market for Glucose Testing and Monitoring, by Region, Through 2026
Table 22 : Global Market for Infectious Disease Testing, by Region, Through 2026
Table 23 : Global Market for Pregnancy and Fertility Testing, by Region, Through 2026
Table 24 : Global Market for Hemoglobin and Hemostasis, by Region, Through 2026
Table 25 : Global Deaths from Cancer, 2015 and 2030
Table 26 : Global Market for Tumor Markers, by Region, Through 2026
Table 27 : Global Market for Urinalysis/Urine Chemistry, by Region, Through 2026
Table 28 : Global Market for Others, by Region, Through 2026
Table 29 : Global Market for Point of Care Diagnostics, by Product, Through 2026
Table 30 : Global Market for Hardware in Point of Care Diagnostics, by Region, Through 2026
Table 31 : Global Market for Software in Point of Care Diagnostics, by Region, Through 2026
Table 32 : Global Market for Point of Care Diagnostics, by End User, Through 2026
Table 33 : Global Market for Point of Care Diagnostics in Home Care Settings, by Region, Through 2026
Table 34 : Estimated Number of Hospitals Beds Available, by Country, 2018-2019
Table 35 : Estimated Nursing Homes Residents in U.S., by U.S. State, 2020
Table 36 : Number of Hospice Providers in America, by Type, in 2018
Table 37 : Global Market for Point of Care Diagnostics in Hospital and Critical Care End Use, by Region, Through 2026
Table 38 : Global Market for Point of Care Diagnostics, by Region, Through 2026
Table 39 : North American Market for Point of Care Diagnostics, by Test Type, Through 2026
Table 40 : North American Market for Point of Care Diagnostics, by Product, Through 2026
Table 41 : North American Market for Point of Care Diagnostics, by End User, Through 2026
Table 42 : North American Market for Point of Care Diagnostics, by Country, Through 2026
Table 43 : COVID-19 Confirmed Cases and Deaths in the U.S., by State
Table 44 : STI Cases Across Canada, by Gender and Disease Type, 2018
Table 45 : European Market for Point of Care Diagnostics, by Test Type, Through 2026
Table 46 : European Market for Point of Care Diagnostics, by Product, Through 2026
Table 47 : European Market for Point of Care Diagnostics, by End User, Through 2026
Table 48 : European Market for Point of Care Diagnostics, by Country, Through 2026
Table 49 : Geriatric Population in Germany, 2015-2030
Table 50 : Health Spending and Financing in France, 2005-2017
Table 51 : New Cancer Cases in Spain, by Type, 2020
Table 52 : Asia-Pacific Market for Point of Care Diagnostics, by Test Type, Through 2026
Table 53 : Asia-Pacific Market for Point of Care Diagnostics, by Product, Through 2026
Table 54 : Asia-Pacific Market for Point of Care Diagnostics, by End User, Through 2026
Table 55 : Asia-Pacific Market for Point of Care Diagnostics, by Country, Through 2026
Table 56 : Japanese Market Statistics
Table 57 : Commonly Used POC Devices in the Indian Healthcare System.
Table 58 : Rest of the World Market for Point of Care Diagnostics, by Test Type, Through 2026
Table 59 : Rest of the World Market for Point of Care Diagnostics, by Product, Through 2026
Table 60 : Rest of the World Market for Point of Care Diagnostics, by End User, Through 2026
Table 61 : Middle East and North Africa HIV and AIDS Statistics, 2019
Table 62 : Recent Developments in Point of Care Diagnostics Market, 2019-2021
Table 63 : Abbaxis: Point of Care Diagnostic/Testing Products
Table 64 : Abbott: Financials, 2016-2020
Table 65 : Abbott: Product Portfolio, by Business Segment
Table 66 : Abbott: Point of Care Diagnostic Products
Table 67 : Abbott: Recent Developments, 2021
Table 68 : BD: Product Portfolio
Table 69 : BioRad Laboratories Product Portfolio
Table 70 : Cardinal Health Inc.: Product Portfolio
Table 71 : Chembio Diagnostics Inc.: Product Portfolio
Table 72 : Chembio Diagnostics: Recent Developments, 2021
Table 73 : Danaher Product Portfolio
Table 74 : EKF Diagnostics Holdings plc: Product Portfolio
Table 75 : ELITech Group: Product Portfolio
Table 76 : Esaote S.p.A.: Product Portfolio
Table 77 : GE: Financial Performance, 2019 and 2020
Table 78 : GE Healthcare: Point of Care Diagnostics Products
Table 79 : LifeScan Product Portfolio
Table 80 : Lumos Diagnostics Holdings Ltd.: Product Portfolio
Table 81 : Medtronic plc: Product Portfolio
Table 82 : Mindray Medical International Ltd.: Product Portfolio
Table 83 : Nexus DX: Product Portfolio
Table 84 : Nova Biomedical Product Portfolio
Table 85 : OraSure Technologies: Product Portfolio
Table 86 : Philips Healthcare: Product Portfolio
Table 87 : Quidel Corp.: Product Portfolio
Table 88 : F. Hoffmann-La Roche Ltd.: Financials, 2019
Table 89 : F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2016-2018
Table 90 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 91 : F. Hoffmann-La Roche Ltd.: Recent Developments, 2021
Table 92 : Siemens Healthcare GmbH: Product Segments
Table 93 : Siemens Healthcare GmbH: Point of Care Diagnostics Products
Table 94 : Siemens Healthcare GmbH: Financials, 2019
Table 95 : Siemens Healthcare GmbH: Key Developments, 2020
Table 96 : Thermo Fisher Scientific: Product Portfolio
Table 97 : Thermo Fisher Scientific: Key Developments, 2021
Table 98 : Zoetis Inc. Product Portfolio
Related Report
